Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

SELL
$0.62 - $0.85 $71,854 - $98,510
-115,895 Reduced 71.96%
45,150 $37,000
Q4 2023

Feb 14, 2024

BUY
$0.67 - $1.35 $107,900 - $217,410
161,045 New
161,045 $111,000
Q2 2023

Aug 11, 2023

SELL
$1.04 - $1.4 $837,339 - $1.13 Million
-805,134 Reduced 95.73%
35,937 $40,000
Q1 2023

May 16, 2023

BUY
$1.15 - $1.89 $943,449 - $1.55 Million
820,391 Added 3967.07%
841,071 $1.17 Million
Q4 2022

Feb 14, 2023

SELL
$0.96 - $1.6 $16,428 - $27,380
-17,113 Reduced 45.28%
20,680 $23,000
Q3 2022

Nov 14, 2022

SELL
$1.33 - $2.6 $131,457 - $256,984
-98,840 Reduced 72.34%
37,793 $61,000
Q2 2022

Aug 15, 2022

BUY
$0.67 - $1.4 $66,440 - $138,831
99,165 Added 264.67%
136,633 $179,000
Q1 2022

May 16, 2022

SELL
$1.23 - $3.31 $134,384 - $361,637
-109,256 Reduced 74.46%
37,468 $46,000
Q4 2021

Feb 14, 2022

SELL
$2.89 - $4.43 $40,928 - $62,737
-14,162 Reduced 8.8%
146,724 $478,000
Q3 2021

Nov 15, 2021

BUY
$3.36 - $4.62 $405,232 - $557,195
120,605 Added 299.41%
160,886 $669,000
Q2 2021

Aug 11, 2021

BUY
$2.82 - $5.01 $67,319 - $119,598
23,872 Added 145.48%
40,281 $168,000
Q4 2020

Feb 16, 2021

BUY
$1.64 - $3.42 $7,466 - $15,571
4,553 Added 38.4%
16,409 $50,000
Q3 2020

Nov 16, 2020

SELL
$2.18 - $2.84 $603,369 - $786,041
-276,775 Reduced 95.89%
11,856 $29,000
Q1 2020

May 15, 2020

BUY
$1.5 - $4.52 $432,946 - $1.3 Million
288,631 New
288,631 $696,000
Q1 2019

May 15, 2019

SELL
$1.47 - $3.06 $18,663 - $38,849
-12,696 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$2.66 - $15.93 $120,298 - $720,434
-45,225 Reduced 78.08%
12,696 $34,000
Q3 2018

Nov 14, 2018

BUY
$12.07 - $16.0 $699,106 - $926,736
57,921 New
57,921 $901,000
Q2 2018

Aug 14, 2018

SELL
$9.36 - $13.25 $188,753 - $267,199
-20,166 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$8.49 - $11.82 $171,209 - $238,362
20,166 New
20,166 $205,000

Others Institutions Holding SELB

About SELECTA BIOSCIENCES INC


  • Ticker SELB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 152,712,992
  • Market Cap $128M
  • Description
  • Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...
More about SELB
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.